Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.
Reardon DA, Vredenburgh JJ, Desjardins A, Peters KB, Sathornsumetee S, Threatt S, Sampson JH, Herndon JE 2nd, Coan A, McSherry F, Rich JN, McLendon RE, Zhang S, Friedman HS.
Reardon DA, et al. Among authors: mcsherry f.
J Neurooncol. 2012 Jul;108(3):499-506. doi: 10.1007/s11060-012-0848-x. Epub 2012 Mar 10.
J Neurooncol. 2012.
PMID: 22407177
Free PMC article.
Clinical Trial.